id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-1881	Quaglino, Pietro; Fava, Paolo; Tonella, Luca; Rubatto, Marco; Ribero, Simone; Ferro, Maria Teresa	Treatment of Advanced Metastatic Melanoma	2021	12	.pdf	application/pdf	8529	547	58	The long-term results of trials with follow-up data of patients treated with tar- geted or immunotherapies reported median OS rates around 24 months, with 5-year survival rates around 35-40%. The long-term results of the trials with follow-up data of patients treated with targeted or immunotherapies reported median OS rates around 24 months, with 5-year survival rates around 35-40% [3].	cache/dpc-1881.pdf	txt/dpc-1881.txt